Yoshihisa Sasou

Direttore/Membro del Consiglio presso Medicago, Inc.

Health Technology

Profilo

Yoshihisa Sasou is currently a Director at Medicago, Inc. since 2013.
Previously, he worked as a General Manager-Corporate Communications at Mitsubishi Tanabe Pharma Corp.

Posizioni attive di Yoshihisa Sasou

Società	Posizione	Inizio
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Direttore/Membro del Consiglio	18/09/2013

Tutte le posizioni attive di Yoshihisa Sasou

Precedenti posizioni note di Yoshihisa Sasou

Società	Posizione	Fine
MITSUBISHI TANABE PHARMA CORPORATION	Public Communications Contact	-

Vedi nel dettaglio l'esperienza di Yoshihisa Sasou

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Yoshihisa Sasou

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Mitsubishi Tanabe Pharma Corp. Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.	Health Technology
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Health Technology